Global Vascular Closure Devices Market to Reach $1.2 Billion by 2027

Abstract: Global Vascular Closure Devices Market to Reach $1. 2 Billion by 2027. Amid the COVID-19 crisis, the global market for Vascular Closure Devices estimated at US$731.

New York, July 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Closure Devices Industry" - https://www.reportlinker.com/p05896474/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Passive Approximators, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$783.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Active Approximators segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $302.2 Million, While China is Forecast to Grow at 8.2% CAGR

The Vascular Closure Devices market in the U.S. is estimated at US$302.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$119.6 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

External Hemostatic Devices Segment to Record 4.6% CAGR

In the global External Hemostatic Devices segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.9 Million in the year 2020 will reach a projected size of US$125.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87.6 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 36 Featured)

• Abbott Laboratories

• Advanced Vascular Dynamics

• Cardinal Health, Inc.

• Cardival Medical, Inc.

• Endocor GmbH

• Medtronic PLC

• Merit Medical Systems Inc.

• Morris Innovative Inc.

• Teleflex Incorporated

• Terumo Corporation

• Transluminal Technologies LLC

• Tricol Medical Inc.

• Vivasure Medical Ltd.

Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vascular Closure Devices - A Prelude
Benefits
Active Approximators
Passive Approximators
External Hemostatic Devices
Vascular Closure Devices to Witness Steady Growth Post COVID-19
Interventional Cardiology to Dominate the Market
Passive Approximators Lead the Market
Femoral Access Type Leads the Market
United States Holds a Dominant Share, Asia-Pacific to Witness
Rapid Growth
Competition
Growth Restraints

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Medical Device Companies Focus on Developing Advanced
Biomechanical VCDs
Increasing Demand for Large-bore Vascular Closure Devices
Select Large Bore Closure Devices
Cardiovascular Diseases: A Significant Contributor to Market
Growth
EXHIBIT 1: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others
EXHIBIT 2: Global Annual Medical Cost of CVD in US$ Billion:
(2010-2030)
Rising Preference for Minimally Invasive Procedures Boosts
Market Prospects
Aging Population Drives Demand for Vascular Closure Devices
EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of
Number of People Aged 65+ Years in Million by Geographic
Region for the Years 2019 and 2030
Life Expectancy for Select Countries in Number of Years: 2019
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years
2016 & 2018
Recent Approvals and Launches
Essential Medical Inc Receives FDA Clearance for its Large-Bore
Vascular Closure Device
Vascade MVP Vascular Closure System Obtains Approval from FDA
Large Bore PerQseal Closure Device Introduced in Europe
Cordis Introduces Mynx Control Vascular Closure Device
FDA Approves Teleflex?s Vascular Closure Device
Vasorum Set to Commercialize a New Vascular Closure Device
across the US

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vascular Closure
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Vascular Closure Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Vascular Closure Devices
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Passive
Approximators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Passive Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Passive Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Active
Approximators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Active Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Active Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for External
Hemostatic Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for External Hemostatic Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for External Hemostatic
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Interventional
Cardiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Interventional Cardiology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Interventional
Cardiology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Interventional
Radiology/Vascular Surgery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Interventional
Radiology/Vascular Surgery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Interventional
Radiology/Vascular Surgery by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Femoral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Femoral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Femoral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Radial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Radial by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Radial by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 26: USA Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 29: USA Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 30: USA 15-Year Perspective for Vascular Closure Devices
by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 32: USA Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 33: USA 15-Year Perspective for Vascular Closure Devices
by Access - Percentage Breakdown of Value Sales for Femoral and
Radial for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: Canada Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 36: Canada 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: Canada Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 39: Canada 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Canada Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 42: Canada 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

JAPAN
Graying Population Spurs Growth of Vascular Closure Devices
Table 24: Japanese Population by Age Group (2015 & 2040):
Percentage Share Breakdown of Population for 0-14, 15-64 and 65 &
Above Age Groups

Table 43: Japan Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Japan Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 46: Japan Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Japan Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 48: Japan 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Japan Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 51: Japan 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

CHINA
Table 52: China Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: China Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 55: China Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: China Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 57: China 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: China Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 60: China 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

EUROPE
Ageing Demography - An Opportunity Indicator
EXHIBIT 4: European Population by Age Group (2016, 2030 & 2050
): Percentage Share Breakdown by Age Group for 0-14, 15-64,
and 65 & Above
Table 61: Europe Current & Future Analysis for Vascular Closure
Devices by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 62: Europe Historic Review for Vascular Closure Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 63: Europe 15-Year Perspective for Vascular Closure
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Europe Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 66: Europe 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 68: Europe Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 69: Europe 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Europe Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 72: Europe 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

FRANCE
Table 73: France Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: France Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 75: France 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 76: France Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: France Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 78: France 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: France Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 81: France 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

GERMANY
Table 82: Germany Current & Future Analysis for Vascular
Closure Devices by Type - Passive Approximators, Active
Approximators and External Hemostatic Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Germany Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 84: Germany 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 85: Germany Current & Future Analysis for Vascular
Closure Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: Germany Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 87: Germany 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Vascular
Closure Devices by Access - Femoral and Radial - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 89: Germany Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 90: Germany 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

ITALY
Table 91: Italy Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Italy Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Italy 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 94: Italy Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Italy Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 96: Italy 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Italy Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 99: Italy 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 100: UK Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: UK Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: UK 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2020 & 2027

Table 103: UK Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: UK Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 105: UK 15-Year Perspective for Vascular Closure Devices
by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: UK Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 108: UK 15-Year Perspective for Vascular Closure Devices
by Access - Percentage Breakdown of Value Sales for Femoral and
Radial for the Years 2012, 2020 & 2027

SPAIN
Table 109: Spain Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 110: Spain Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 111: Spain 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 112: Spain Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: Spain Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 114: Spain 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 115: Spain Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: Spain Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 117: Spain 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027

RUSSIA
Table 118: Russia Current & Future Analysis for Vascular
Closure Devices by Type - Passive Approximators, Active
Approximators and External Hemostatic Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: Russia Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 120: Russia 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027

Table 121: Russia Current & Future Analysis for Vascular
Closure Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 122: Russia Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 123: Russia 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027

Table 124: Russia Current & Future Analysis for Vascular
Closure Devices by Access - Femoral and Radial - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 125: Russia Historic Review for Vascular Closure Devices

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001